These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3263428)

  • 41. Gamma ray-induced mutants as a tool for the production and characterisation of monoclonal antibodies against HLA-alloantigens.
    Spring B; Pawelec G; Ziegler A
    Tissue Antigens; 1986 Apr; 27(4):201-8. PubMed ID: 3014680
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cross-linking of interleukin 4 to surface molecules on murine T and B lymphocytes.
    Fernandez-Botran R; Uhr JW; Vitetta ES
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4235-9. PubMed ID: 2786209
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Flow cytometry resonance energy transfer suggests an association between low-affinity interleukin 2 binding sites and HLA class I molecules.
    Harel-Bellan A; Krief P; Rimsky L; Farrar WL; Mishal Z
    Biochem J; 1990 May; 268(1):35-40. PubMed ID: 2111701
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interaction of the pre-domain of interleukin-1 with the mature domain.
    Kobayashi Y; Nagatake H; Shimozato O; Watanabe N
    J Biochem; 1997 May; 121(5):896-901. PubMed ID: 9192731
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Homotypic and heterotypic
    Ruggiero FM; Springer S
    Curr Res Immunol; 2022; 3():85-99. PubMed ID: 35647522
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Open MHC Class I Conformers: A Look through the Looking Glass.
    Arosa FA; Esgalhado AJ; Reste-Ferreira D; Cardoso EM
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575902
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potential Role of HLA Class I Antigens in the Glycolytic Metabolism and Motility of Melanoma Cells.
    Peppicelli S; Ruzzolini J; Andreucci E; Bianchini F; Kontos F; Yamada T; Ferrone S; Calorini L
    Cancers (Basel); 2019 Aug; 11(9):. PubMed ID: 31454998
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Killing tumor cells through their surface beta(2)-microglobulin or major histocompatibility complex class I molecules.
    Yang J; Yi Q
    Cancer; 2010 Apr; 116(7):1638-45. PubMed ID: 20143445
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inactivation of human immunodeficiency virus (HIV)-1 envelope-specific CD8+ cytotoxic T lymphocytes by free antigenic peptide: a self-veto mechanism?
    Takahashi H; Nakagawa Y; Leggatt GR; Ishida Y; Saito T; Yokomuro K; Berzofsky JA
    J Exp Med; 1996 Mar; 183(3):879-89. PubMed ID: 8642292
    [TBL] [Abstract][Full Text] [Related]  

  • 50. T-cell activation. VI. Inhibitory and stimulatory effects of anti-major histocompatibility complex class I antibodies in allogeneic mixed lymphocyte culture.
    Röpke M; Röpke C; Claësson MH
    Immunology; 1993 Jun; 79(2):263-9. PubMed ID: 8344704
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells.
    Colonna M; Borsellino G; Falco M; Ferrara GB; Strominger JL
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):12000-4. PubMed ID: 8265660
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activation of natural killer cells via the p75 interleukin 2 receptor.
    Phillips JH; Takeshita T; Sugamura K; Lanier LL
    J Exp Med; 1989 Jul; 170(1):291-6. PubMed ID: 2787381
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Secretion and cell surface expression of IgG1 are impaired in human B lymphoblasts that lack HLA-A, -B, and -C antigens.
    Burlingham WJ; Ceman SS; DeMars R
    Proc Natl Acad Sci U S A; 1989 Oct; 86(20):8005-9. PubMed ID: 2682635
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An immunoregulatory function for the CD8 molecule.
    Kaplan DR; Hambor JE; Tykocinski ML
    Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8512-5. PubMed ID: 2510168
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence for additional subunits associated to the mouse interleukin 2 receptor p55/p75 complex.
    Saragovi H; Malek TR
    Proc Natl Acad Sci U S A; 1990 Jan; 87(1):11-5. PubMed ID: 2296573
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IL-2 receptors on rabbit T-cell lines and their transfectants expressing the human IL-2 receptor alpha chain.
    Yamamura Y; Kotani M; Tsudo M; Karasuyama H; Seto A; Miyasaka M
    Immunology; 1990 Dec; 71(4):502-7. PubMed ID: 2279736
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of intercellular adhesion molecule 1 with the multichain high-affinity interleukin 2 receptor.
    Burton J; Goldman CK; Rao P; Moos M; Waldmann TA
    Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7329-33. PubMed ID: 1976256
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Developmental and tissue-specific expression of the Q5k gene.
    Schwemmle S; Bevec D; Brem G; Urban MB; Baeuerle PA; Weiss EH
    Immunogenetics; 1991; 34(1):28-38. PubMed ID: 1713191
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interleukin (IL)-2 and IL-3 induce distinct but overlapping responses in murine IL-3-dependent 32D cells transduced with human IL-2 receptor beta chain: involvement of tyrosine kinase(s) other than p56lck.
    Otani H; Siegel JP; Erdos M; Gnarra JR; Toledano MB; Sharon M; Mostowski H; Feinberg MB; Pierce JH; Leonard WJ
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2789-93. PubMed ID: 1557384
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Receptor antagonist and selective agonist derivatives of mouse interleukin-2.
    Zurawski SM; Zurawski G
    EMBO J; 1992 Nov; 11(11):3905-10. PubMed ID: 1396584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.